325 related articles for article (PubMed ID: 10371175)
1. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.
Mocroft A; Kirk O; Barton SE; Dietrich M; Proenca R; Colebunders R; Pradier C; dArminio Monforte A; Ledergerber B; Lundgren JD
AIDS; 1999 May; 13(8):943-50. PubMed ID: 10371175
[TBL] [Abstract][Full Text] [Related]
2. Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.
Kowalska JD; Mocroft A; Blaxhult A; Colebunders R; van Lunzen J; Podlekareva D; Hansen AB; Machala L; Yust I; Benfield T;
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1183-8. PubMed ID: 17961102
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study.
Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
BMC Med; 2015 Apr; 13():70. PubMed ID: 25889688
[TBL] [Abstract][Full Text] [Related]
4. Anemia and survival in human immunodeficiency virus.
Lundgren JD; Mocroft A
Clin Infect Dis; 2003; 37 Suppl 4():S297-303. PubMed ID: 14581998
[TBL] [Abstract][Full Text] [Related]
5. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
Harris RJ; Sterne JA; Abgrall S; Dabis F; Reiss P; Saag M; Phillips AN; Chêne G; Gill JM; Justice AC; Rockstroh J; Sabin CA; Mocroft A; Bucher HC; Hogg RS; Monforte AD; May M; Egger M;
Antivir Ther; 2008; 13(8):959-67. PubMed ID: 19195321
[TBL] [Abstract][Full Text] [Related]
7. Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with gender.
Shah S; Smith CJ; Lampe F; Youle M; Johnson MA; Phillips AN; Sabin CA
HIV Med; 2007 Jan; 8(1):38-45. PubMed ID: 17305931
[TBL] [Abstract][Full Text] [Related]
8. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.
Obirikorang C; Yeboah FA
J Biomed Sci; 2009 Nov; 16(1):102. PubMed ID: 19922646
[TBL] [Abstract][Full Text] [Related]
9. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
[TBL] [Abstract][Full Text] [Related]
10. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
[TBL] [Abstract][Full Text] [Related]
11. Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD).
Zhou J; Kumarasamy N;
HIV Med; 2005 May; 6(3):216-23. PubMed ID: 15876289
[TBL] [Abstract][Full Text] [Related]
12. Haemoglobin and anaemia in the SMART study.
Mocroft A; Lifson AR; Touloumi G; Neuhaus J; Fox Z; Palfreeman A; Vjecha MJ; Hodder S; De Wit S; Lundgren JD; Phillips AN;
Antivir Ther; 2011; 16(3):329-37. PubMed ID: 21555815
[TBL] [Abstract][Full Text] [Related]
13. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
15. Anaemia in HIV-infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother-to-child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS).
Odhiambo C; Zeh C; Angira F; Opollo V; Akinyi B; Masaba R; Williamson JM; Otieno J; Mills LA; Lecher SL; Thomas TK
Trop Med Int Health; 2016 Mar; 21(3):373-84. PubMed ID: 26799167
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.
Tugume L; Morawski BM; Abassi M; Bahr NC; Kiggundu R; Nabeta HW; Hullsiek KH; Taseera K; Musubire AK; Schutz C; Muzoora C; Williams DA; Rolfes MA; Meintjes G; Rhein J; Meya DB; Boulware DR
HIV Med; 2017 Jan; 18(1):13-20. PubMed ID: 27126930
[TBL] [Abstract][Full Text] [Related]
17. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
18. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
[TBL] [Abstract][Full Text] [Related]
20. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
